Donna, a long-time Huntington Beach resident, shares her journey living with non-small cell lung cancer (NSCLC). Diagnosed with the rare ERBB2 exon 20 mutation, she recounts the initial…
This video features a presentation at the Best of Lung 2023 conference. Jaime Schneider, MD discusses the latest advancements in targeted therapies for lung cancer. They highlight the…
Dr. Nicolas Girard, MD, PhD, explores new treatments for advanced HER2-positive non-small cell lung cancer (NSCLC). Highlighting the challenges faced by this orphan patient group, he discusses the…
Explore the atypical signs and symptoms of lung cancer, including the rare paraneoplastic syndromes caused by the disease. Learn about small cell carcinoma’s manifestations like Lambert-Eaton myasthenic syndrome,…
Learn about the specifics of treating non-small cell lung cancer (NSCLC) when a KRAS mutation is present. The KRAS gene, often mutated in several cancers including NSCLC, signals…
This presentation delves into the pathophysiology of CML, highlighting its progression from the chronic phase through the accelerated phase to the blast phase.…
Mark A. Socinski, MD, executive medical director at AdventHealth Cancer Institute, recommends immediate comprehensive molecular testing at the time of lung cancer diagnosis. Stating that oncogenic driver mutation…
Erin M. Bertino, MD, medical oncologist at Ohio State University Comprehensive Cancer Center – James, provides a comparison of newly approved drug dacomitinib versus the other available FDA-approved…
Jessica Bauman, MD, assistant professor of hematology/oncology at Fox Chase Cancer Center, discusses recent advancements in non-small cell lung cancer (NSCLC) treatment using targeted RET-fusion mutation therapies. RET-fusion…
Julia Rotow, MD, medical oncologist at Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, reviews new treatment options for non-small cell lung cancer (NSCLC) patients. Dr. Rotow…
